Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

71P - survival outcomes of patients with recurrent malignant ovarian germ cell tumors, a retrospective analysis from a tertiary cancer center

Date

23 Feb 2023

Session

Poster Display session

Presenters

ANNE SRIKANTH

Citation

Annals of Oncology (2023) 8 (1suppl_1): 100811-100811. 10.1016/esmoop/esmoop100811

Authors

A. SRIKANTH1, S. Dey2, R. Nandhana3, S. Rath3, S. Gulia2, N. Lavanya G.1, S. Menon1, B. Rekhi4, P. Popat3, N. Sable5, A. Baheti5, S. Tandon5, S. Jadhav5, T. Shylasree1, S. Chopra1, K. Deodhar5, A. Maheshwari6, J. Ghosh2, S. Gupta2

Author affiliations

  • 1 Tata Memorial Hospital - Tata Memorial Centre, Mumbai/IN
  • 2 Tata Memorial Hospital - Tata Memorial Centre, 400012 - Mumbai/IN
  • 3 Tata Memorial Hospital - Parel, 400012 - Mumbai/IN
  • 4 Tata Memorial Hospital, Mumbai/IN
  • 5 Tata Memorial Centre, Mumbai/IN
  • 6 Tata Memorial Hospital Centre, Mumbai/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 71P

Background

Treatment of recurrent malignant ovarian germ cell tumors (MOGCT) are complex and challenging. There is limited data on outomes of these patientsafter salvage therapy in real world setting.

Methods

This is a retrospective study of all patients diagnosed with recurrent MOGCT at our center between 2013-2017. Out of 43 patients 12 patients were excluded as they have not followed up after first visit. Clinico-pathological and treatment details of 31 patients were extracted from electronic medical records and were included in the analysis.

Results

Table: 71P

VARIABLE PATIENTS (%)
STAGE AT BASELINE IAICIII/IVUnknown 11 (35%)5 (16%)5/3 (16%/9%)7 (22%)
HISTOLOGY DysgerminomaYolk sacTeratomaMixed GCT 8 (26%)6 (19%)10 (32%)7 (22%)
ADEQUACY OF TREATMENT AT BASELINE AdequateInadequateMissing 22 (71%)8 (26%)1 (3%)
SITES OF RECURRENCE Peritoneum+ pelvis-20 (65%)Lymph node- 8 (25%)Liver+ lung- 3 (9%)

Baseline characteristics initial stage, adequacy of treatment, sites of recurrence and treatment were in tabular form. Salvage chemotherapy was given in all patients. Ten (33%) patients who were inadequately treated upfront at outside recieved BEP/ EP as salvage regimen in our centre. Other regimens used were VeIP 8 (25%), TIP 6 (19%) and VIP 4 (13%) Others 3 (10%). After salvage chemotherapy 19 (61%) patients underwent second surgery, R0 resection was achieved in 13 (42%) patients. After median follow up of 66 months, 21 patients were alive (18-with no disease, and 3 were alive with stable teratoma component) after salvage therapy, and 10 patients were dead. Out of 13 patients with yolk sac histology (Pure yolk sac -6; Mixed GCT-7) only 6 could be salvaged. Those who could not be salvaged had effusions or extensive liver disease. Two patients out of 8 reccurent dysgerminoma had bulky multi station lymph nodal relapse could not be salvaged. The median PFS was after relapse was 26 months and median OS was 33 months post relapse.

Conclusions

Adequate treatment at initial diagnosis is of paramount importance along with active surveillance to minimize default rates especially in low middle-Income countries. 67% of our recurrent cases were effectively salvaged. If managed at experienced centres with multidisciplinary approach using salvage chemotherapy and surgery, majority of recurrences can result in long term cure.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.